Europe Prescription Digital Therapeutics (PDTx) Market to 2032

Overview

The Europe Prescription Digital Therapeutics (PDTx) Market is expected to reach a 1,222.46 USD Billion by 2032 and is projected to grow at a CAGR of 30.55% from 2025 to 2032.

Revenue, 2024 (USD Billion)
229.82
Forecast, 2032 (USD Billion)
1,222.46
CAGR, 2024 - 2032
30.55%
Report Coverage
Europe

Europe Prescription Digital Therapeutics (PDTx) Market 2018-2032 USD Billion

Europe Prescription Digital Therapeutics (PDTx) Market , Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 229.82 USD Billion
  • Projected Market Size (2032): 1,222.46 USD Billion
  • CAGR (2025-2032): 30.55%

Key Findings of Europe Prescription Digital Therapeutics (PDTx) Market

  • The Europe Prescription Digital Therapeutics (PDTx) Market was valued at 229.82 USD Billion in 2024.
  • The Europe Prescription Digital Therapeutics (PDTx) Market is likely to grow at a CAGR of 30.55% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Medication Augmentation in Category Segment accounted for the largest share of the market with a revenue of 206.02 USD Billion
  • The fastest growing segment Android in App Accessibility Segment grew Fastest with a CAGR of 32.02% during the forecast period from 2024 to 2032.

Europe Prescription Digital Therapeutics (PDTx) Market Scope

Europe Prescription Digital Therapeutics (PDTx) Market Segmentation & Scope
Mechanism
  • Output Mechanism
  • Input Mechanism
Application
  • Substance Use Disorders (SUD)
  • Insomnia
  • Opioid Use Disorder (OUD)
  • Attention Deficit/Hyperactivity Disorder (ADHD)
  • Multiple Sclerosis
  • Epilepsy
  • Alzheimer's Disease
  • Austism Spectrum Disorder
  • Migraine
  • Others
  • Oncology
  • Inflammation
  • Movement Disorders
  • Pain Management
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Major Depressive Disorder
  • Metabolic Conditions
App Type
  • Web App
  • Native App
App Accessibility
  • Windows
  • iOS
  • Android
Services
  • Medical Microservices
  • Behavioral Microservices
Treatment
  • Monotherapy
  • Outpatient Treatment
Category
  • Medication Replacement
  • Medication Augmentation
Software
  • Software for Opioid Use Disorder
  • Others
  • Software for Respiratory Conditions
  • Software for Mental Health
  • Software for Diabetes

Europe Prescription Digital Therapeutics (PDTx) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Billion
Market Value in 2024 229.82 USD Billion
Market Value in 2032 1,222.46 USD Billion
CAGR (2025-2032) 30.55%
Historic Data 2016-2023
Market Segments Covered Mechanism,Application ,App Type ,App Accessibility,Services,Treatment,Category,Software

Regional Insights:

  • Leading Market (2024-2032): Europe, leading in terms of revenue 229.82 USD Billion in 2024
    • Key Country: Germany, leading in terms of revenue with value of 56.50 USD Billion in 2024.

Segments and Scope

  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By Mechanism
    • Input Mechanism is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 184.80 USD Billion in the year 2024.
    • Input Mechanism is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 31.38 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By Application
    • Metabolic Conditions is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 100.98 USD Billion in the year 2024.
    • Pain Management is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 28.64 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By App Type
    • Native App is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 161.69 USD Billion in the year 2024.
    • Native App is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 31.65 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By App Accessibility
    • Android is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 133.55 USD Billion in the year 2024.
    • Android is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 32.02 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By Services
    • Behavioral Microservices is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 184.15 USD Billion in the year 2024.
    • Behavioral Microservices is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 31.18 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By Treatment
    • Outpatient Treatment is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 173.48 USD Billion in the year 2024.
    • Outpatient Treatment is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 31.37 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By Category
    • Medication Augmentation is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 206.02 USD Billion in the year 2024.
    • Medication Augmentation is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 31.44 % in forecast period 2025-2032.
  • Europe Prescription Digital Therapeutics (PDTx) Market to 2032, By Software
    • Software for Diabetes is the largest segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a revenue of 121.92 USD Billion in the year 2024.
    • Software for Mental Health is the Fastest growing segment in Europe Prescription Digital Therapeutics (PDTx) Market to 2032 with a Growth rate of 29.75 % in forecast period 2025-2032.

Europe Prescription Digital Therapeutics (PDTx) Market Company Share Analysis

 
Europe Prescription Digital Therapeutics (PDTx) Market  Company Share Analysis
Europe Prescription Digital Therapeutics (PDTx) Market  Company Share Analysis

Europe Prescription Digital Therapeutics (PDTx) Market Geographical Sales Distribution, 2018-2032 USD Billion

Europe Prescription Digital Therapeutics (PDTx) Market  Geographical Sales Distribution, 2018-2032 USD Billion

Europe Prescription Digital Therapeutics (PDTx) Market Company Profiling

Europe Prescription Digital Therapeutics (PDTx) Market  Company Profiling
Frequently Asked Questions
The Europe Prescription Digital Therapeutics (PDTx) Market is segmented based on Segmentation Mechanism,Application ,App Type ,App Accessibility,Services,Treatment,Category,Software.
Europe Prescription Digital Therapeutics (PDTx) Market was valued at USD 229.82(Revenue in USD Billion) in 2022.
Europe Prescription Digital Therapeutics (PDTx) Market is projected to grow at a CAGR of 30.55% during the forecast period of 2024 to 2032.
The Medication Augmentation segment is expected to dominate the Europe Prescription Digital Therapeutics (PDTx) Market , holding a largest market share of 206.02 USD Billion in 2024

Coming Soon....

Europe Prescription Digital Therapeutics (PDTx) Market Scope

Europe Prescription Digital Therapeutics (PDTx) Market Segmentation & Scope
Mechanism
  • Output Mechanism
  • Input Mechanism
Application
  • Substance Use Disorders (SUD)
  • Insomnia
  • Opioid Use Disorder (OUD)
  • Attention Deficit/Hyperactivity Disorder (ADHD)
  • Multiple Sclerosis
  • Epilepsy
  • Alzheimer's Disease
  • Austism Spectrum Disorder
  • Migraine
  • Others
  • Oncology
  • Inflammation
  • Movement Disorders
  • Pain Management
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Major Depressive Disorder
  • Metabolic Conditions
App Type
  • Web App
  • Native App
App Accessibility
  • Windows
  • iOS
  • Android
Services
  • Medical Microservices
  • Behavioral Microservices
Treatment
  • Monotherapy
  • Outpatient Treatment
Category
  • Medication Replacement
  • Medication Augmentation
Software
  • Software for Opioid Use Disorder
  • Others
  • Software for Respiratory Conditions
  • Software for Mental Health
  • Software for Diabetes
Frequently Asked Questions
The Europe Prescription Digital Therapeutics (PDTx) Market is segmented based on Segmentation Mechanism,Application ,App Type ,App Accessibility,Services,Treatment,Category,Software.
Europe Prescription Digital Therapeutics (PDTx) Market was valued at USD 229.82(Revenue in USD Billion) in 2022.
Europe Prescription Digital Therapeutics (PDTx) Market is projected to grow at a CAGR of 30.55% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Prescription Digital Therapeutics (PDTx) Market for final year is USD 1,222.46 (USD Billion).

Europe Prescription Digital Therapeutics (PDTx) Market Company Profiling

Europe Prescription Digital Therapeutics (PDTx) Market  Company Profiling
Frequently Asked Questions
The Europe Prescription Digital Therapeutics (PDTx) Market is segmented based on Segmentation Mechanism,Application ,App Type ,App Accessibility,Services,Treatment,Category,Software.
Europe Prescription Digital Therapeutics (PDTx) Market was valued at USD 229.82(Revenue in USD Billion) in 2022.
Europe Prescription Digital Therapeutics (PDTx) Market is projected to grow at a CAGR of 30.55% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Prescription Digital Therapeutics (PDTx) Market for final year is USD 1,222.46 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.